These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1143 related items for PubMed ID: 19863849

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Oral therapies for the treatment of pulmonary arterial hypertension: a population-based cost-minimization analysis.
    Dranitsaris G, Mehta S.
    Appl Health Econ Health Policy; 2009; 7(1):43-59. PubMed ID: 19558194
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cost Effectiveness of Bosentan for Pulmonary Arterial Hypertension: A Systematic Review.
    You R, Qian X, Tang W, Xie T, Zeng F, Chen J, Zhang Y, Liu J.
    Can Respir J; 2018; 2018():1015239. PubMed ID: 30581511
    [Abstract] [Full Text] [Related]

  • 5. Long-term follow-up after conversion from intravenous epoprostenol to oral therapy with bosentan or sildenafil in 13 patients with pulmonary arterial hypertension.
    Johnson RF, Loyd JE, Mullican AL, Fink CA, Robbins IM.
    J Heart Lung Transplant; 2007 Apr; 26(4):363-9. PubMed ID: 17403478
    [Abstract] [Full Text] [Related]

  • 6. Hemodynamics in pulmonary arterial hypertension (PAH): do they explain long-term clinical outcomes with PAH-specific therapy?
    Steele P, Strange G, Wlodarczyk J, Dalton B, Stewart S, Gabbay E, Keogh A.
    BMC Cardiovasc Disord; 2010 Feb 22; 10():9. PubMed ID: 20170553
    [Abstract] [Full Text] [Related]

  • 7. Meta-analysis of randomized controlled trials on treatment of pulmonary arterial hypertension.
    He B, Zhang F, Li X, Tang C, Lin G, Du J, Jin H.
    Circ J; 2010 Jul 22; 74(7):1458-64. PubMed ID: 20519876
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [The treatment of idiopathic pulmonary artery hypertension and its relation to systemic scleroderma].
    Humbert M.
    Rev Med Interne; 2007 Dec 22; 28 Suppl 4():S273-6. PubMed ID: 17961866
    [No Abstract] [Full Text] [Related]

  • 11. Treatment patterns and resource utilization and costs among patients with pulmonary arterial hypertension in the United States.
    Angalakuditi M, Edgell E, Beardsworth A, Buysman E, Bancroft T.
    J Med Econ; 2010 Dec 22; 13(3):393-402. PubMed ID: 20608882
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Specific drugs for the treatment of pulmonary arterial hypertension - current status].
    Stähler G.
    Dtsch Med Wochenschr; 2008 Oct 22; 133 Suppl 6():S183-6. PubMed ID: 18814092
    [Abstract] [Full Text] [Related]

  • 14. [Pulmonary arterial hypertension and systemic sclerosis].
    Launay D, Humbert M, Hachulla E.
    Presse Med; 2006 Dec 22; 35(12 Pt 2):1929-37. PubMed ID: 17159719
    [Abstract] [Full Text] [Related]

  • 15. Directing therapy in pulmonary arterial hypertension using a target 6 min walk distance.
    Porhownik NR, Myers R, Bshouty Z.
    Can Respir J; 2013 Dec 22; 20(2):111-5. PubMed ID: 23616968
    [Abstract] [Full Text] [Related]

  • 16. [Pulmonary hypertension treatment: future prospects].
    Baloira A.
    Arch Bronconeumol; 2007 Mar 22; 43(3):131-5. PubMed ID: 17386188
    [No Abstract] [Full Text] [Related]

  • 17. Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil.
    Launay D, Sitbon O, Le Pavec J, Savale L, Tchérakian C, Yaïci A, Achouh L, Parent F, Jais X, Simonneau G, Humbert M.
    Rheumatology (Oxford); 2010 Mar 22; 49(3):490-500. PubMed ID: 20015974
    [Abstract] [Full Text] [Related]

  • 18. Long-term sildenafil added to intravenous epoprostenol in patients with pulmonary arterial hypertension.
    Simonneau G, Rubin LJ, Galiè N, Barst RJ, Fleming TR, Frost A, Engel P, Kramer MR, Serdarevic-Pehar M, Layton GR, Sitbon O, Badesch DB, PACES Study Group.
    J Heart Lung Transplant; 2014 Jul 22; 33(7):689-97. PubMed ID: 24815795
    [Abstract] [Full Text] [Related]

  • 19. Sildenafil for pulmonary hypertension.
    Lee AJ, Chiao TB, Tsang MP.
    Ann Pharmacother; 2005 May 22; 39(5):869-84. PubMed ID: 15827074
    [Abstract] [Full Text] [Related]

  • 20. Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension.
    Mathai SC, Girgis RE, Fisher MR, Champion HC, Housten-Harris T, Zaiman A, Hassoun PM.
    Eur Respir J; 2007 Mar 22; 29(3):469-75. PubMed ID: 17079256
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.